Narrow spectrum, broad utility: Reassessing cephalexin and cefazolin beyond cellulitis
Authors:
- 17 December 2025
- journal article
- Published by University of Toronto Press Inc. (UTPress) in Journal of the Association of Medical Microbiology and Infectious Disease Canada
- Vol. 10 (4) , 276-280
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED StudyAnnals of Emergency Medicine, 2024
- Bacteroides and related species: The keystone taxa of the human gut microbiotaAnaerobe, 2024
- The long and the short of pediatric emergency department antibiotic prescribing: A retrospective observational studyThe American Journal of Emergency Medicine, 2023
- Treatment Failure and Adverse Events After Amoxicillin-Clavulanate vs Amoxicillin for Pediatric Acute SinusitisJAMA, 2023
- Revisiting β‐Lactams for Treatment of Urinary Tract Infections: Assessing Clinical Outcomes of Twice‐Daily Cephalexin for Empiric Treatment of Uncomplicated Urinary Tract InfectionsThe Journal of Clinical Pharmacology, 2022
- A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection in the Era of “Bad Bugs, Few Drugs”International Journal of Antimicrobial Agents, 2020
- A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2019
- Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract InfectionsJAMA, 2017
- Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanateDiagnostic Microbiology and Infectious Disease, 2007
- In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxilEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989